Guest blog by Dave Mead, Director of Business Development, Isogenica Limited
I recently joined One Nucleus ’ BioWednesday panel to debate whether using Government R&D incentives are worth it.
So, are they? As a growing biotech company, Isogenica Limited has experience in accessing grant opportunities and other R&D incentives. Yet, for many start-ups, it can be a steep learning curve to work out what’s available and the best use of precious time and resources. Alongside panellists from Octane OC and EY, I collated the following useful…